Bone Mineral Density Effects of Zoledronate in Postmenopausal Women With Breast Cancer

NCT00213980 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

68

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Zoledronate

Sponsor

University of Wisconsin, Madison